ArriVent BioPharma Files 8-K Report
Ticker: AVBP · Form: 8-K · Filed: Jul 21, 2025 · CIK: 1868279
| Field | Detail |
|---|---|
| Company | Arrivent Biopharma, INC. (AVBP) |
| Form Type | 8-K |
| Filed Date | Jul 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
ArriVent BioPharma filed an 8-K on 7/21/25, check for updates.
AI Summary
On July 21, 2025, ArriVent BioPharma, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates that ArriVent BioPharma, Inc. has submitted a current report to the SEC, which may contain updates on significant company events or financial information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K submission and does not disclose any immediate risks or negative events.
Key Players & Entities
- ArriVent BioPharma, Inc. (company) — Registrant
- July 21, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-41929 (commission_file_number) — SEC File Number
- 18 Campus Boulevard, Suite 100 (address) — Principal executive offices
- Newtown Square, PA 19073 (address) — Principal executive offices location
- (628) 277-4836 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are reported by ArriVent BioPharma, Inc. in this 8-K filing?
The provided text for the 8-K filing lists "Other Events" as an item information, but does not specify the nature of these events.
What is the significance of the filing date July 21, 2025?
July 21, 2025, is the date of the earliest event reported in the 8-K filing by ArriVent BioPharma, Inc.
Where are ArriVent BioPharma, Inc.'s principal executive offices located?
ArriVent BioPharma, Inc.'s principal executive offices are located at 18 Campus Boulevard, Suite 100, Newtown Square, PA 19073.
What is the SEC file number for ArriVent BioPharma, Inc.?
The SEC file number for ArriVent BioPharma, Inc. is 001-41929.
What is the SIC code for ArriVent BioPharma, Inc.?
The Standard Industrial Classification (SIC) code for ArriVent BioPharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 21, 2025 regarding ArriVent BioPharma, Inc. (AVBP).